Publication details

BCR signalling proficient chronic lymphocytic leukaemia cells are prone to rituximab mediated elimination in vivo.

Investor logo
Authors

PAVLASOVÁ Gabriela BORSKÝ Marek SVOBODOVÁ Veronika MUSILOVÁ Kateřina ČERNÁ Kateřina ŠEDA Václav NOVOTNÁ Jitka BRYCHTOVÁ Yvona DOUBEK Michael POSPÍŠILOVÁ Šárka MAYER Jiří MRÁZ Marek

Year of publication 2017
Type Conference abstract
MU Faculty or unit

Central European Institute of Technology

Citation
Description BCR signalling proficient chronic lymphocytic leukaemia cells are prone to rituximab mediated elimination in vivo., BCR signalling proficient chronic lymphocytic leukaemia cells are prone to rituximab mediated elimination in vivo.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info